ctrl K

AI Score

Unlock

SAB Biotherapeutics Inc. (SABSW)

AI Score

Unlock

0.03

0.00 (1.69%)

At close: Feb 28, 2025, 3:59 PM

0.03

5.08%

After-hours: Feb 28, 2025, 04:00 PM EST

SAB Biotherapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	2.24M	23.9M	60.88M	55.24M	3.44M
Cost of Revenue	3.75M	3.29M	1.65M	n/a	n/a
Gross Profit	-1.51M	20.61M	59.22M	55.24M	3.44M
Operating Income	-38.08M	-28.92M	-13.39M	20.56M	-8.67M
Interest Income	584.97K	71.07K	23.11K	26.13K	113.13K
Pretax Income	-42.19M	-18.72M	-17.14M	20.12M	-8.99M
Net Income	-42.19M	-18.74M	-17.44M	20.12M	-9.42M
Selling & General & Admin	20.05M	16.38M	17.09M	6.77M	4.1M
Research & Development	16.52M	36.44M	57.18M	27.91M	8.02M
Other Expenses	n/a	-23.9M	-60.88M	4K	2.59K
Operating Expenses	36.57M	28.92M	13.39M	34.68M	12.12M
Interest Expense	315.28K	301.58K	294.46K	469.15K	428.48K
Selling & Marketing Expenses	-3.75M	n/a	n/a	n/a	n/a
Cost & Expenses	40.31M	28.92M	13.39M	34.68M	12.12M
Income Tax	n/a	25.63K	299.95K	473.15K	431.07K
Shares Outstanding (Basic)	5.52M	4.35M	2.73M	2.54M	43.47M
Shares Outstanding (Diluted)	5.52M	4.35M	2.73M	2.7M	43.47M
EPS (Basic)	-7.64	-4.31	-6.38	7.92	-0.22
EPS (Diluted)	-7.64	-4.31	-6.38	7.45	-0.22
EBITDA	-38.13M	-15.12M	-15.2M	21.14M	-8.23M
Depreciation & Amortization	3.75M	3.29M	1.65M	548.18K	323.41K